Barclays

Pinnacle West Announces Proposed Public Offering of $650 Million of Common Stock

Retrieved on: 
Wednesday, February 28, 2024

Pinnacle West Capital Corp. (NYSE: PNW) (“Pinnacle West”) announced today that it is commencing a registered public offering of $650 million of its common stock in connection with the forward sale agreements described below, subject to market and other conditions.

Key Points: 
  • Pinnacle West Capital Corp. (NYSE: PNW) (“Pinnacle West”) announced today that it is commencing a registered public offering of $650 million of its common stock in connection with the forward sale agreements described below, subject to market and other conditions.
  • Pinnacle West intends to grant the underwriters the option to purchase up to an additional $97.5 million of its common stock.
  • Such borrowed shares of Pinnacle West’s common stock will be delivered by the forward sellers for sale to the underwriters in the offering.
  • Pinnacle West will not initially receive any proceeds from the sale of shares of its common stock by the forward sellers or their affiliates to the underwriters.

CRH Continues Share Buyback Program

Retrieved on: 
Thursday, February 29, 2024

CRH plc, the leading provider of building materials solutions, is pleased to announce that it has completed the latest phase of its share buyback program, returning a further $0.3 billion of cash to shareholders.

Key Points: 
  • CRH plc, the leading provider of building materials solutions, is pleased to announce that it has completed the latest phase of its share buyback program, returning a further $0.3 billion of cash to shareholders.
  • This brings total cash returned to shareholders under our ongoing share buyback program to $7.3 billion since its commencement in May 2018.
  • Barclays will conduct the Buyback on CRH’s behalf and will make trading decisions under the Buyback independently of CRH in accordance with certain pre-set parameters.
  • The purpose of the Buyback is to reduce the share capital of CRH.

FIS Announces $2.25 Billion Senior Note Tender Offers for Certain Outstanding Senior Notes

Retrieved on: 
Tuesday, February 27, 2024

Notes may be validly withdrawn at any time at or prior to 5:00 p.m. (Eastern time) on March 4, 2024, unless extended with respect to any Offer.

Key Points: 
  • Notes may be validly withdrawn at any time at or prior to 5:00 p.m. (Eastern time) on March 4, 2024, unless extended with respect to any Offer.
  • Accordingly, Holders should not tender any Notes that they do not wish to be accepted for purchase.
  • FIS reserves the right, subject to applicable law, to waive the Maximum Purchase Condition with respect to any Offer.
  • King & Co, Inc. will act as the Information and Tender Agent for the Offers.

Barclays and Blackstone Credit & Insurance Agree to Sale of Credit Card Receivables

Retrieved on: 
Tuesday, February 27, 2024

Barclays PLC ("Barclays") and Blackstone Credit & Insurance (“Blackstone”) today announced that Barclays Bank Delaware ("BBDE") has entered into an agreement with insurance accounts managed by Blackstone’s Asset Based Finance group, to sell approximately US$1.1 billion of currently outstanding credit card receivables (the “Transaction”) in relation to a defined set of Barclays-branded credit card accounts in the United States of America (the “Accounts”).

Key Points: 
  • Barclays PLC ("Barclays") and Blackstone Credit & Insurance (“Blackstone”) today announced that Barclays Bank Delaware ("BBDE") has entered into an agreement with insurance accounts managed by Blackstone’s Asset Based Finance group, to sell approximately US$1.1 billion of currently outstanding credit card receivables (the “Transaction”) in relation to a defined set of Barclays-branded credit card accounts in the United States of America (the “Accounts”).
  • This is the first in a series of activities Barclays plans to conduct to reduce its risk-weighted assets (RWAs) and create additional lending capacity for BBDE.
  • As part of the Transaction, BBDE will enter into a long-term strategic forward flow sale and servicing arrangement with Blackstone related to the Accounts.
  • Barclays Bank PLC will invest into the Transaction alongside Blackstone’s insurance accounts.

ICON plc to Present at Upcoming Investor Conferences

Retrieved on: 
Monday, February 26, 2024

ICON plc , (NASDAQ: ICLR) a world-leading clinical research organization powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the TD Cowen 44th Annual Healthcare Conference on Tuesday, March 5, 2024 at 11:10 am ET and Dr. Steve Cutler, CEO of ICON plc, will present at the Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024, at 2:05 pm ET.

Key Points: 
  • ICON plc , (NASDAQ: ICLR) a world-leading clinical research organization powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the TD Cowen 44th Annual Healthcare Conference on Tuesday, March 5, 2024 at 11:10 am ET and Dr. Steve Cutler, CEO of ICON plc, will present at the Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024, at 2:05 pm ET.

Arcturus Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference

Retrieved on: 
Monday, February 26, 2024

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the Company will present at a Fireside Chat hosted by Barclays 26th Annual Global Healthcare Conference in Miami, on Thursday, March 14, 2024, at 11:45 a.m. Eastern Time.

Key Points: 
  • Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the Company will present at a Fireside Chat hosted by Barclays 26th Annual Global Healthcare Conference in Miami, on Thursday, March 14, 2024, at 11:45 a.m. Eastern Time.
  • A webcast and replay of the presentation will be available on the “Investor Relations/Events” section of the Company’s website at: https://ir.arcturusrx.com/investor-calendar .

MarketAxess Appoints Ilene Fiszel Bieler as Chief Financial Officer

Retrieved on: 
Monday, February 26, 2024

MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading platform for fixed-income securities, today announced the appointment of Ilene Fiszel Bieler as Chief Financial Officer.

Key Points: 
  • MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading platform for fixed-income securities, today announced the appointment of Ilene Fiszel Bieler as Chief Financial Officer.
  • Ms. Fiszel Bieler is currently expected to start with MarketAxess on or about May 22, 2024.
  • Ms. Fiszel Bieler replaces Christopher Gerosa, who left the Company on January 31, 2024.
  • “MarketAxess is an S&P500 company with a remarkable history of over two decades of innovation and leadership in the fixed-income space,” said Ms. Fiszel Bieler.

Cross River Launches Premier Fintech Investment Banking Franchise

Retrieved on: 
Monday, February 26, 2024

The Investment Banking team will be a part of CRB Securities, LLC, and will be led by industry veterans Benjamin Samuels and Henry Pinnell as Co-Heads of Investment Banking.

Key Points: 
  • The Investment Banking team will be a part of CRB Securities, LLC, and will be led by industry veterans Benjamin Samuels and Henry Pinnell as Co-Heads of Investment Banking.
  • “We are proud to launch our investment banking division of our broker dealer with two well-respected professionals in the industry, combining decades of experience in both the fintech industry and capital markets,” said Gilles Gade, Founder and CEO of Cross River.
  • Henry Pinnell joins as Co-Head of Investment Banking from SVB Securities, where he was a Senior Managing Director and led the Fintech Investment Banking effort.
  • Prior to SVB Henry was a Managing Director in the Investment Banking Division at Barclays Bank PLC where he led the firm’s Emerging Fintech franchise.

Twist Bioscience to Present at Upcoming Investor Conferences

Retrieved on: 
Thursday, February 22, 2024

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its executives will participate in fireside chats at the following upcoming investor conferences:

Key Points: 
  • Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its executives will participate in fireside chats at the following upcoming investor conferences:
    Patrick Finn, Ph.D., president and COO, and Adam Laponis, CFO, will participate in a fireside chat at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5 in Boston, MA; fireside chat at 11:10 a.m. Eastern Time.
  • Emily Leproust, Ph.D., CEO and co-founder, and Adam Laponis, CFO, will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12 in Miami, FL; fireside chat at 7:30 a.m. Eastern Time.
  • The fireside chats will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here .
  • A replay of the fireside chats will be archived for a period of 30 days following the conclusion of the live events.

Elevance Health Announces Appearance at Barclays 26th Annual Global Healthcare Conference

Retrieved on: 
Thursday, February 22, 2024

Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Barclays 26th Annual Global Healthcare Conference in Miami, on March 14 at 9:30 a.m. Eastern Daylight Time (EDT).

Key Points: 
  • Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Barclays 26th Annual Global Healthcare Conference in Miami, on March 14 at 9:30 a.m. Eastern Daylight Time (EDT).
  • All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link.
  • For those unable to listen to the live webcast, a replay will be available for 90 days following the presentation.
  • To listen to the live webcast, please visit Elevance Health’s website www.elevancehealth.com at least 15 minutes early to download and install any necessary audio software.